Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report

Affiliations

• ¹ Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. joseph_arboleda@meei.harvard.edu.
• ² Grupo de Neurociencias de Antioquia de la Universidad de Antioquia, Medellin, Colombia.
• ³ Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
• ⁴ Boston College, Boston, MA, USA.
• ⁵ Massachusetts General Hospital and Department of Neurology, Harvard Medical School, Boston, MA, USA.
• ⁶ Brigham and Women's Hospital and the Department of Neurology, Harvard Medical School, Boston, MA, USA.
• ⁷ Universidad Escuela de Ingenieria de Antioquia-EIA, Medellin, Colombia.
• ⁸ The Banner Alzheimer's Institute, Phoenix, AZ, USA.
• ⁹ University of Arizona, Tucson, AZ, USA.
• ¹⁰ Arizona State University, Tempe, AZ, USA.
• ¹¹ Massachusetts General Hospital and the Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
• ¹² Department of Psychology, Gordon College, Wenham, MA, USA.
• ¹³ Neuroscience Research Institute, Department of Molecular Cellular Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA, USA.
• ¹⁴ Neurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, USA.
• ¹⁵ Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
• ¹⁶ Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.
• ¹⁷ Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
• ¹⁸ UK Dementia Research Institute at UCL, London, UK.
• ¹⁹ Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
• ²⁰ Center for Personalized Medicine, Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.
• ²¹ Department of Pathology, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.
• ²² Mass Eye and Ear and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
• ²³ Massachusetts General Hospital and Department of Radiology, Harvard Medical School, Boston, MA, USA.
• ²⁴ The Banner Alzheimer's Institute, Phoenix, AZ, USA. eric.reiman@bannerhealth.com.
• ²⁵ University of Arizona, Tucson, AZ, USA. eric.reiman@bannerhealth.com.
• ²⁶ Arizona State University, Tempe, AZ, USA. eric.reiman@bannerhealth.com.
• ²⁷ Neurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, USA. eric.reiman@bannerhealth.com.
• ²⁸ Grupo de Neurociencias de Antioquia de la Universidad de Antioquia, Medellin, Colombia. yquiroz@mgh.harvard.edu.
• ²⁹ Massachusetts General Hospital and Department of Neurology, Harvard Medical School, Boston, MA, USA. yquiroz@mgh.harvard.edu.
• ³⁰ Massachusetts General Hospital and the Department of Psychiatry, Harvard Medical School, Boston, MA, USA. yquiroz@mgh.harvard.edu.